Article
Protein kinase C as a tumor suppressor.
Seminars in cancer biology - 1 Feb 2018
Newton Alexandra C
Abstract excerpt
Protein kinase C (PKC) has historically been considered an oncoprotein. This stems in large part from the discovery in the early 1980s that PKC is directly activated by tumor-promoting phorbol esters. Yet three decades of clinical trials using PKC inhibitors in cancer therapies not only failed, but in some cases worsened patient outcome. Why has targeting PKC in cancer eluded successful therapies? Recent studies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
